StageSeed VC | Alive
Last Raised$3.1M | 13 yrs ago
Corhythm is developing an implantable treatment that detects early onset of atrial fibrillation and chronic heart failure. The device uses recent advances in semiconductor technology and materials science to provide pacing and defibrillation, and delivers targeted medications when an atrial fibrillation is detected.
Missing: Corhythm's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Corhythm's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Corhythm Frequently Asked Questions (FAQ)
Where is Corhythm's headquarters?
Corhythm's headquarters is located at 12500 Network Blvd., San Antonio.
What is Corhythm's latest funding round?
Corhythm's latest funding round is Seed VC.
How much did Corhythm raise?
Corhythm raised a total of $3.1M.
Who are the investors of Corhythm?
Investors of Corhythm include Texas Emerging Technology Fund.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.